急性肾损伤
医学
重症监护医学
生物标志物
生物医学
尿量
肌酐
内科学
生物信息学
生物化学
生物
化学
作者
Zhu Xiao,Qiong Huang,Yuqi Yang,Min Liu,Qiaohui Chen,Jia Huang,Yuting Xiang,Xuejun Long,Tianjiao Zhao,Xiaoyuan Wang,Xiaoyu Zhu,Shiqi Tu,Kelong Ai
出处
期刊:Theranostics
[Ivyspring International Publisher]
日期:2022-01-01
卷期号:12 (6): 2963-2986
被引量:22
摘要
Many factors such as trauma and COVID-19 cause acute kidney injury (AKI). Late AKI have a very high incidence and mortality rate. Early diagnosis of AKI provides a critical therapeutic time window for AKI treatment to prevent progression to chronic renal failure. However, the current clinical detection based on creatinine and urine output isn't effective in diagnosing early AKI. In recent years, the early diagnosis of AKI has made great progress with the advancement of information technology, nanotechnology, and biomedicine. These emerging methods are mainly divided into two aspects: First, predicting AKI through models construct by machine learning; Second, early diagnosis of AKI through detection of newly-discovered early biomarkers. Currently, these methods have shown great potential and become an attractive tool for the early diagnosis of AKI. Therefore, it is very important to discuss and summarize these methods for the early diagnosis of AKI. In this review, we first systematically summarize the application of machine learning in AKI prediction algorithms and specific scenarios. In addition, we introduce the key role of early biomarkers in the progress of AKI, and then comprehensively summarize the application of emerging detection technologies for early AKI. Finally, we discuss current challenges and prospects of machine learning and biomarker detection. The review is expected to provide new insights for early diagnosis of AKI, and provided important inspiration for the design of early diagnosis of other major diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI